Is Werewolf Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: HOWL) stock is to Strong Buy HOWL stock.
Out of 3 analysts, 2 (66.67%) are recommending HOWL as a Strong Buy, 1 (33.33%) are recommending HOWL as a Buy, 0 (0%) are recommending HOWL as a Hold, 0 (0%) are recommending HOWL as a Sell, and 0 (0%) are recommending HOWL as a Strong Sell.
What is HOWL's forecast return on equity (ROE) for 2023-2025?
(NASDAQ: HOWL) forecast ROE is -95.59%, which is considered weak.
What is HOWL's Price Target?
According to 3 Wall Street analysts that have issued a 1 year HOWL price target, the average HOWL price target is $11.10, with the highest HOWL stock price forecast at $15.00 and the lowest HOWL stock price forecast at $8.30.
On average, Wall Street analysts predict that Werewolf Therapeutics's share price could reach $11.10 by May 25, 2024. The average Werewolf Therapeutics stock price prediction forecasts a potential upside of 228.4% from the current HOWL share price of $3.38.
What is HOWL's forecast return on assets (ROA) for 2023-2025?
(NASDAQ: HOWL) forecast ROA is -59.33%, which is lower than the forecast US Biotechnology industry average of 11.82%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.